Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Tomer Israely and Sharon Melamed.
Tomer Israely
Connection Strength
0.808
Sharon Melamed
  1. Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus. J Biol Chem. 2021 Jan-Jun; 296:100470.
    View in: PubMed
    Score: 0.233
  2. A single dose of recombinant VSV-?G-spike vaccine provides protection against SARS-CoV-2 challenge. Nat Commun. 2020 12 16; 11(1):6402.
    View in: PubMed
    Score: 0.230
  3. Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2. JCI Insight. 2021 06 22; 6(12).
    View in: PubMed
    Score: 0.060
  4. Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection. Nano Lett. 2021 06 09; 21(11):4774-4779.
    View in: PubMed
    Score: 0.059
  5. Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody. Nat Commun. 2021 02 11; 12(1):944.
    View in: PubMed
    Score: 0.058
  6. Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities. Clin Microbiol Infect. 2020 Dec; 26(12):1658-1662.
    View in: PubMed
    Score: 0.056
  7. The coding capacity of SARS-CoV-2. Nature. 2021 01; 589(7840):125-130.
    View in: PubMed
    Score: 0.056
  8. A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes. Nat Commun. 2020 08 27; 11(1):4303.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.